

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.45289544 |
| 2 | vocalization behavior (GO:0071625) | 5.44126849 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.39252676 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.38853428 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.31415424 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.25262588 |
| 7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.19765897 |
| 8 | behavioral response to nicotine (GO:0035095) | 5.14753280 |
| 9 | protein localization to synapse (GO:0035418) | 5.13839192 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.10312134 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.93604157 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.93194087 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.87053499 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 4.71170914 |
| 15 | glutamate secretion (GO:0014047) | 4.63112244 |
| 16 | exploration behavior (GO:0035640) | 4.51058312 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 4.49875414 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.42888907 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.39562194 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 4.38373224 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.32072531 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.28795301 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.24798035 |
| 24 | neuron recognition (GO:0008038) | 4.22573254 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.20603439 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.16919332 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 4.03695446 |
| 28 | presynaptic membrane assembly (GO:0097105) | 4.02429208 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.94682729 |
| 30 | axonal fasciculation (GO:0007413) | 3.88775866 |
| 31 | neurotransmitter secretion (GO:0007269) | 3.88432449 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 3.86123971 |
| 33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.80111848 |
| 34 | postsynaptic membrane organization (GO:0001941) | 3.75854559 |
| 35 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.75665098 |
| 36 | long-term memory (GO:0007616) | 3.75352108 |
| 37 | transmission of nerve impulse (GO:0019226) | 3.74904150 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.73712946 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.72782772 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68762797 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.67943766 |
| 42 | regulation of synapse structural plasticity (GO:0051823) | 3.67550829 |
| 43 | presynaptic membrane organization (GO:0097090) | 3.66317502 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.64600255 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.59960051 |
| 46 | serotonin metabolic process (GO:0042428) | 3.59120086 |
| 47 | regulation of synaptic plasticity (GO:0048167) | 3.57457195 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.56969001 |
| 49 | long-term synaptic potentiation (GO:0060291) | 3.51698866 |
| 50 | startle response (GO:0001964) | 3.51527203 |
| 51 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.49128680 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46437344 |
| 53 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.45335059 |
| 54 | sulfation (GO:0051923) | 3.42616741 |
| 55 | response to histamine (GO:0034776) | 3.41364894 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.41314989 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.39456792 |
| 58 | behavioral defense response (GO:0002209) | 3.39053464 |
| 59 | behavioral fear response (GO:0001662) | 3.39053464 |
| 60 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.38937519 |
| 61 | * dendrite morphogenesis (GO:0048813) | 3.33479821 |
| 62 | proline transport (GO:0015824) | 3.31310195 |
| 63 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.31029838 |
| 64 | synaptic vesicle endocytosis (GO:0048488) | 3.30891487 |
| 65 | neuronal action potential (GO:0019228) | 3.30148454 |
| 66 | primary amino compound metabolic process (GO:1901160) | 3.30113876 |
| 67 | regulation of vesicle fusion (GO:0031338) | 3.30094102 |
| 68 | dendritic spine organization (GO:0097061) | 3.28512371 |
| 69 | neurotransmitter transport (GO:0006836) | 3.26716918 |
| 70 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.26390159 |
| 71 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.25930018 |
| 72 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25300368 |
| 73 | membrane depolarization (GO:0051899) | 3.23272354 |
| 74 | regulation of dendritic spine development (GO:0060998) | 3.22723141 |
| 75 | cellular potassium ion homeostasis (GO:0030007) | 3.21628365 |
| 76 | innervation (GO:0060384) | 3.20354911 |
| 77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.20114630 |
| 78 | positive regulation of synapse assembly (GO:0051965) | 3.18619411 |
| 79 | learning (GO:0007612) | 3.17577422 |
| 80 | positive regulation of dendritic spine development (GO:0060999) | 3.15618229 |
| 81 | fear response (GO:0042596) | 3.14368824 |
| 82 | synapse assembly (GO:0007416) | 3.12284600 |
| 83 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.11364988 |
| 84 | neuromuscular process controlling balance (GO:0050885) | 3.11200154 |
| 85 | regulation of glutamate secretion (GO:0014048) | 3.05787979 |
| 86 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.03957411 |
| 87 | membrane depolarization during action potential (GO:0086010) | 3.02337932 |
| 88 | regulation of neurotransmitter secretion (GO:0046928) | 3.01699938 |
| 89 | regulation of neurotransmitter levels (GO:0001505) | 3.00485101 |
| 90 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.00210600 |
| 91 | NADH dehydrogenase complex assembly (GO:0010257) | 3.00210600 |
| 92 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.00210600 |
| 93 | synapse organization (GO:0050808) | 2.98364750 |
| 94 | protein polyglutamylation (GO:0018095) | 2.98325613 |
| 95 | mechanosensory behavior (GO:0007638) | 2.97419382 |
| 96 | membrane hyperpolarization (GO:0060081) | 2.96828532 |
| 97 | regulation of respiratory system process (GO:0044065) | 2.96633008 |
| 98 | neuronal ion channel clustering (GO:0045161) | 2.94841274 |
| 99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.93405374 |
| 100 | regulation of synaptic transmission (GO:0050804) | 2.93180868 |
| 101 | auditory behavior (GO:0031223) | 2.93111304 |
| 102 | neuromuscular process (GO:0050905) | 2.92365640 |
| 103 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.92155267 |
| 104 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.92102152 |
| 105 | dopamine transport (GO:0015872) | 2.91651417 |
| 106 | * synaptic transmission (GO:0007268) | 2.91402982 |
| 107 | response to auditory stimulus (GO:0010996) | 2.90360347 |
| 108 | activation of protein kinase A activity (GO:0034199) | 2.89718349 |
| 109 | retinal ganglion cell axon guidance (GO:0031290) | 2.86649506 |
| 110 | adult walking behavior (GO:0007628) | 2.86510083 |
| 111 | cochlea development (GO:0090102) | 2.86039643 |
| 112 | regulation of respiratory gaseous exchange (GO:0043576) | 2.84520649 |
| 113 | positive regulation of synaptic transmission (GO:0050806) | 2.84016894 |
| 114 | behavioral response to cocaine (GO:0048148) | 2.83973093 |
| 115 | cerebellar granule cell differentiation (GO:0021707) | 2.83139501 |
| 116 | neuromuscular synaptic transmission (GO:0007274) | 2.81903054 |
| 117 | action potential (GO:0001508) | 2.79546093 |
| 118 | somite development (GO:0061053) | 2.78232579 |
| 119 | nucleobase catabolic process (GO:0046113) | 2.77987848 |
| 120 | regulation of synapse maturation (GO:0090128) | 2.77911965 |
| 121 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.75628277 |
| 122 | detection of light stimulus involved in visual perception (GO:0050908) | 2.75628277 |
| 123 | cell proliferation in forebrain (GO:0021846) | 2.74082838 |
| 124 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.71784008 |
| 125 | response to pheromone (GO:0019236) | 2.69171361 |
| 126 | dopamine biosynthetic process (GO:0042416) | 2.68672833 |
| 127 | potassium ion import (GO:0010107) | 2.68579785 |
| 128 | regulation of membrane repolarization (GO:0060306) | 2.67243558 |
| 129 | axon ensheathment in central nervous system (GO:0032291) | 2.65152562 |
| 130 | central nervous system myelination (GO:0022010) | 2.65152562 |
| 131 | protein complex biogenesis (GO:0070271) | 2.61868229 |
| 132 | fucose catabolic process (GO:0019317) | 2.61508300 |
| 133 | L-fucose metabolic process (GO:0042354) | 2.61508300 |
| 134 | L-fucose catabolic process (GO:0042355) | 2.61508300 |
| 135 | spinal cord development (GO:0021510) | 2.61093384 |
| 136 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.60356469 |
| 137 | indole-containing compound metabolic process (GO:0042430) | 2.57001021 |
| 138 | negative regulation of astrocyte differentiation (GO:0048712) | 2.56886533 |
| 139 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.55761954 |
| 140 | synaptic transmission, cholinergic (GO:0007271) | 2.55642667 |
| 141 | behavioral response to ethanol (GO:0048149) | 2.55452951 |
| 142 | membrane repolarization during action potential (GO:0086011) | 2.50116382 |
| 143 | nonmotile primary cilium assembly (GO:0035058) | 2.49334217 |
| 144 | response to amphetamine (GO:0001975) | 2.48344417 |
| 145 | multicellular organismal signaling (GO:0035637) | 2.46653212 |
| 146 | atrial cardiac muscle cell action potential (GO:0086014) | 2.46321257 |
| 147 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.46166300 |
| 148 | limb bud formation (GO:0060174) | 2.44351085 |
| 149 | regulation of neurotransmitter uptake (GO:0051580) | 2.43958094 |
| 150 | regulation of action potential (GO:0098900) | 2.43788982 |
| 151 | retinal cone cell development (GO:0046549) | 2.42999725 |
| 152 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.42236534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.25841297 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84471499 |
| 3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.23921089 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19639279 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12178491 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78531553 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78531553 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72608085 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67857745 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.66429200 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65619490 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55621873 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.51834304 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48125409 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.47331484 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41093905 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.29791257 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24127622 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22812095 |
| 20 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22748956 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22362889 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.18878039 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14617731 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.05451436 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03141457 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.02233673 |
| 27 | * EWS_26573619_Chip-Seq_HEK293_Human | 2.02030007 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00813340 |
| 29 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.00304427 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99109175 |
| 31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.95682482 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91232974 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86123082 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.85882684 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81514426 |
| 36 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79419736 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70935642 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68843945 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66079630 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61612518 |
| 41 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.60490153 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59918409 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57497198 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.54302120 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52815998 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52479782 |
| 47 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.49957873 |
| 48 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45727608 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44073352 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41651528 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41305459 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40648702 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39558196 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38249507 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37935775 |
| 56 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37167090 |
| 57 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36314112 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35363290 |
| 59 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35160864 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34770453 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34716528 |
| 62 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34205038 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32844654 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31009574 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30856465 |
| 66 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28068643 |
| 67 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.27985578 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27575716 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27315394 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25625729 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25625729 |
| 72 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.20556880 |
| 73 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20353078 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18486658 |
| 75 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18439347 |
| 76 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17176085 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14186425 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12383041 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11794668 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11705764 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11343501 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11343501 |
| 83 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11150618 |
| 84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10719162 |
| 85 | * AR_19668381_ChIP-Seq_PC3_Human | 1.10316398 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10000112 |
| 87 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09127177 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08340879 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.08220548 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07894251 |
| 91 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07108138 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06906152 |
| 93 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06010382 |
| 94 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05514669 |
| 95 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05017677 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04940832 |
| 97 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04844627 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04406634 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04196476 |
| 100 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.03304708 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03016479 |
| 102 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02311275 |
| 103 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02204759 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01870351 |
| 105 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.01319561 |
| 106 | * JUN_21703547_ChIP-Seq_K562_Human | 1.01299658 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01279035 |
| 108 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01070002 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99947925 |
| 110 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99409628 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98207120 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97997721 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96984182 |
| 114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96900732 |
| 115 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95722198 |
| 116 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95314062 |
| 117 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93598579 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93231225 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92705212 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92287958 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90055444 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89589796 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87896280 |
| 124 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87670249 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87173108 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85945948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.30627702 |
| 2 | MP0003880_abnormal_central_pattern | 5.59425530 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.03341265 |
| 4 | MP0004270_analgesia | 3.98118907 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.38740942 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.30138942 |
| 7 | MP0002064_seizures | 3.10285697 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.04077561 |
| 9 | * MP0002572_abnormal_emotion/affect_behav | 2.84265732 |
| 10 | MP0009046_muscle_twitch | 2.82726415 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.73789911 |
| 12 | MP0001486_abnormal_startle_reflex | 2.64349978 |
| 13 | MP0002272_abnormal_nervous_system | 2.56923848 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.54692560 |
| 15 | MP0002736_abnormal_nociception_after | 2.52076128 |
| 16 | MP0000778_abnormal_nervous_system | 2.34794903 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.31741241 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.30779488 |
| 19 | MP0002822_catalepsy | 2.18224843 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.13359383 |
| 21 | * MP0001440_abnormal_grooming_behavior | 2.12676900 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.03378749 |
| 23 | MP0002184_abnormal_innervation | 1.99538470 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.97985502 |
| 25 | MP0008877_abnormal_DNA_methylation | 1.96819380 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.91625212 |
| 27 | MP0001529_abnormal_vocalization | 1.90275699 |
| 28 | MP0001970_abnormal_pain_threshold | 1.88923086 |
| 29 | MP0003329_amyloid_beta_deposits | 1.86379660 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.73404299 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.71307476 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.70157646 |
| 33 | MP0004924_abnormal_behavior | 1.70157646 |
| 34 | MP0000955_abnormal_spinal_cord | 1.61632215 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.60372692 |
| 36 | MP0008569_lethality_at_weaning | 1.58045719 |
| 37 | MP0004858_abnormal_nervous_system | 1.55316492 |
| 38 | MP0002160_abnormal_reproductive_system | 1.52899638 |
| 39 | MP0001905_abnormal_dopamine_level | 1.52846714 |
| 40 | MP0001984_abnormal_olfaction | 1.52037046 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.49933551 |
| 42 | * MP0002882_abnormal_neuron_morphology | 1.47787986 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.45873521 |
| 44 | MP0003879_abnormal_hair_cell | 1.42438722 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.41651474 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.40633361 |
| 47 | MP0003122_maternal_imprinting | 1.40448661 |
| 48 | MP0005253_abnormal_eye_physiology | 1.35392166 |
| 49 | MP0003787_abnormal_imprinting | 1.35177887 |
| 50 | MP0004885_abnormal_endolymph | 1.34215804 |
| 51 | MP0000049_abnormal_middle_ear | 1.33765722 |
| 52 | MP0004142_abnormal_muscle_tone | 1.32018123 |
| 53 | MP0004133_heterotaxia | 1.31866478 |
| 54 | MP0001188_hyperpigmentation | 1.31714785 |
| 55 | MP0002938_white_spotting | 1.21203543 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.20946472 |
| 57 | MP0004742_abnormal_vestibular_system | 1.19058025 |
| 58 | * MP0002152_abnormal_brain_morphology | 1.17764879 |
| 59 | MP0003119_abnormal_digestive_system | 1.17663648 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.16283180 |
| 61 | MP0003136_yellow_coat_color | 1.12830869 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.11947352 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.09673178 |
| 64 | MP0003633_abnormal_nervous_system | 1.08926787 |
| 65 | MP0005389_reproductive_system_phenotype | 1.07168654 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.05830330 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.04682776 |
| 68 | MP0003631_nervous_system_phenotype | 1.04067476 |
| 69 | MP0003937_abnormal_limbs/digits/tail_de | 1.03902913 |
| 70 | MP0003121_genomic_imprinting | 1.03243134 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.01779736 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.01562888 |
| 73 | MP0004043_abnormal_pH_regulation | 0.98221599 |
| 74 | MP0003646_muscle_fatigue | 0.98204088 |
| 75 | MP0001485_abnormal_pinna_reflex | 0.95320740 |
| 76 | MP0000751_myopathy | 0.95251426 |
| 77 | MP0005174_abnormal_tail_pigmentation | 0.94848274 |
| 78 | MP0003634_abnormal_glial_cell | 0.94386546 |
| 79 | MP0003890_abnormal_embryonic-extraembry | 0.94175767 |
| 80 | MP0005195_abnormal_posterior_eye | 0.93937702 |
| 81 | MP0005171_absent_coat_pigmentation | 0.93336098 |
| 82 | MP0002229_neurodegeneration | 0.93191274 |
| 83 | MP0005409_darkened_coat_color | 0.92628265 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.92475665 |
| 85 | MP0003632_abnormal_nervous_system | 0.92228749 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.92085201 |
| 87 | MP0004147_increased_porphyrin_level | 0.91986993 |
| 88 | MP0000920_abnormal_myelination | 0.91251811 |
| 89 | MP0002653_abnormal_ependyma_morphology | 0.90508674 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.89463411 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.89249569 |
| 92 | MP0001177_atelectasis | 0.87494401 |
| 93 | MP0004085_abnormal_heartbeat | 0.84658164 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.84515157 |
| 95 | MP0003283_abnormal_digestive_organ | 0.84156700 |
| 96 | MP0009250_abnormal_appendicular_skeleto | 0.83828778 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.82975223 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.81185074 |
| 99 | MP0004130_abnormal_muscle_cell | 0.80470919 |
| 100 | MP0001919_abnormal_reproductive_system | 0.79576018 |
| 101 | MP0005535_abnormal_body_temperature | 0.77614905 |
| 102 | MP0005499_abnormal_olfactory_system | 0.77567043 |
| 103 | MP0005394_taste/olfaction_phenotype | 0.77567043 |
| 104 | MP0003195_calcinosis | 0.76843192 |
| 105 | MP0003938_abnormal_ear_development | 0.76781005 |
| 106 | MP0002928_abnormal_bile_duct | 0.76308950 |
| 107 | MP0008872_abnormal_physiological_respon | 0.76153925 |
| 108 | MP0008874_decreased_physiological_sensi | 0.76094121 |
| 109 | MP0003861_abnormal_nervous_system | 0.74671227 |
| 110 | MP0002102_abnormal_ear_morphology | 0.74640154 |
| 111 | MP0000604_amyloidosis | 0.74434521 |
| 112 | MP0001293_anophthalmia | 0.74234322 |
| 113 | MP0000026_abnormal_inner_ear | 0.72035489 |
| 114 | MP0003690_abnormal_glial_cell | 0.69361848 |
| 115 | MP0001943_abnormal_respiration | 0.66238007 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.65449146 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.65403956 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.64665025 |
| 119 | MP0002090_abnormal_vision | 0.64193999 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.59984386 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.59198413 |
| 122 | MP0001664_abnormal_digestion | 0.57945439 |
| 123 | MP0004484_altered_response_of | 0.56853027 |
| 124 | MP0004233_abnormal_muscle_weight | 0.55578180 |
| 125 | MP0010769_abnormal_survival | 0.54680734 |
| 126 | MP0003075_altered_response_to | 0.54593955 |
| 127 | MP0002082_postnatal_lethality | 0.54336155 |
| 128 | MP0010770_preweaning_lethality | 0.54336155 |
| 129 | MP0010768_mortality/aging | 0.51343534 |
| 130 | MP0005187_abnormal_penis_morphology | 0.51325835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.70464396 |
| 2 | Myokymia (HP:0002411) | 6.23453999 |
| 3 | Focal seizures (HP:0007359) | 6.00619661 |
| 4 | Visual hallucinations (HP:0002367) | 5.61067652 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.76412929 |
| 6 | Absence seizures (HP:0002121) | 4.67448852 |
| 7 | Atonic seizures (HP:0010819) | 4.56710356 |
| 8 | Dialeptic seizures (HP:0011146) | 4.30692263 |
| 9 | Febrile seizures (HP:0002373) | 4.14761172 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.10566079 |
| 11 | Hyperventilation (HP:0002883) | 4.05935022 |
| 12 | Broad-based gait (HP:0002136) | 3.92689440 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.79079565 |
| 14 | Pancreatic cysts (HP:0001737) | 3.38629788 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.28999107 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.22103353 |
| 17 | Action tremor (HP:0002345) | 3.20957719 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.20091713 |
| 19 | Excessive salivation (HP:0003781) | 3.18699998 |
| 20 | Drooling (HP:0002307) | 3.18699998 |
| 21 | Amblyopia (HP:0000646) | 3.17580823 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 3.12020284 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 3.12020284 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 3.10307596 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.05324067 |
| 26 | True hermaphroditism (HP:0010459) | 3.04706662 |
| 27 | Anxiety (HP:0000739) | 2.93287076 |
| 28 | Nephronophthisis (HP:0000090) | 2.93114020 |
| 29 | Truncal ataxia (HP:0002078) | 2.91254163 |
| 30 | Dysmetria (HP:0001310) | 2.90374427 |
| 31 | Poor eye contact (HP:0000817) | 2.88153607 |
| 32 | Congenital stationary night blindness (HP:0007642) | 2.86989371 |
| 33 | Absent speech (HP:0001344) | 2.81922945 |
| 34 | Dysdiadochokinesis (HP:0002075) | 2.75502224 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.71990718 |
| 36 | Depression (HP:0000716) | 2.70305145 |
| 37 | Mutism (HP:0002300) | 2.62072121 |
| 38 | Abnormal eating behavior (HP:0100738) | 2.61985056 |
| 39 | Progressive inability to walk (HP:0002505) | 2.59599517 |
| 40 | Pendular nystagmus (HP:0012043) | 2.58221320 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.57249637 |
| 42 | Ankle clonus (HP:0011448) | 2.56973277 |
| 43 | Impaired social interactions (HP:0000735) | 2.56287260 |
| 44 | Abnormal social behavior (HP:0012433) | 2.56287260 |
| 45 | Fetal akinesia sequence (HP:0001989) | 2.50439179 |
| 46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.49966187 |
| 47 | Type II lissencephaly (HP:0007260) | 2.49331293 |
| 48 | Spastic gait (HP:0002064) | 2.48633730 |
| 49 | Hemiparesis (HP:0001269) | 2.44336073 |
| 50 | Abnormality of the renal medulla (HP:0100957) | 2.41529819 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.40217838 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.40217838 |
| 53 | Hyperalaninemia (HP:0003348) | 2.40217838 |
| 54 | Chronic hepatic failure (HP:0100626) | 2.39611661 |
| 55 | Medial flaring of the eyebrow (HP:0010747) | 2.39385923 |
| 56 | Abnormality of the lower motor neuron (HP:0002366) | 2.38386215 |
| 57 | Diplopia (HP:0000651) | 2.36145666 |
| 58 | Abnormality of binocular vision (HP:0011514) | 2.36145666 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34396981 |
| 60 | Genetic anticipation (HP:0003743) | 2.33470628 |
| 61 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.33102612 |
| 62 | Scanning speech (HP:0002168) | 2.32571245 |
| 63 | Abnormality of the corticospinal tract (HP:0002492) | 2.31496555 |
| 64 | Generalized myoclonic seizures (HP:0002123) | 2.30916934 |
| 65 | Postural instability (HP:0002172) | 2.25741701 |
| 66 | Stereotypic behavior (HP:0000733) | 2.25343132 |
| 67 | Urinary urgency (HP:0000012) | 2.24284452 |
| 68 | Megalencephaly (HP:0001355) | 2.24011441 |
| 69 | Inability to walk (HP:0002540) | 2.22479803 |
| 70 | Limb dystonia (HP:0002451) | 2.22194126 |
| 71 | Polyphagia (HP:0002591) | 2.21968259 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 2.21702060 |
| 73 | Termporal pattern (HP:0011008) | 2.20441367 |
| 74 | Insidious onset (HP:0003587) | 2.20441367 |
| 75 | Abnormality of salivation (HP:0100755) | 2.20090155 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.19362720 |
| 77 | Blue irides (HP:0000635) | 2.18634369 |
| 78 | Amyotrophic lateral sclerosis (HP:0007354) | 2.18412129 |
| 79 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.13377227 |
| 80 | Impaired smooth pursuit (HP:0007772) | 2.12138862 |
| 81 | Optic nerve hypoplasia (HP:0000609) | 2.10826205 |
| 82 | Abnormality of the renal cortex (HP:0011035) | 2.10441985 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.10309351 |
| 84 | Protruding tongue (HP:0010808) | 2.09900751 |
| 85 | Torticollis (HP:0000473) | 2.09096381 |
| 86 | Small hand (HP:0200055) | 2.08599385 |
| 87 | Intention tremor (HP:0002080) | 2.07514093 |
| 88 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.07018597 |
| 89 | Lissencephaly (HP:0001339) | 2.06673223 |
| 90 | Bradykinesia (HP:0002067) | 2.05149722 |
| 91 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.04836130 |
| 92 | Akinesia (HP:0002304) | 2.03713638 |
| 93 | Cystic liver disease (HP:0006706) | 2.02129941 |
| 94 | Pheochromocytoma (HP:0002666) | 1.99347975 |
| 95 | Short tibia (HP:0005736) | 1.97428222 |
| 96 | Anencephaly (HP:0002323) | 1.94888702 |
| 97 | Focal dystonia (HP:0004373) | 1.94833592 |
| 98 | Delusions (HP:0000746) | 1.94795985 |
| 99 | Sclerocornea (HP:0000647) | 1.94402404 |
| 100 | Lower limb muscle weakness (HP:0007340) | 1.93675824 |
| 101 | Papilledema (HP:0001085) | 1.93271114 |
| 102 | Thickened helices (HP:0000391) | 1.92609730 |
| 103 | Congenital primary aphakia (HP:0007707) | 1.92377614 |
| 104 | Genital tract atresia (HP:0001827) | 1.91582405 |
| 105 | Congenital, generalized hypertrichosis (HP:0004540) | 1.90536307 |
| 106 | Decreased central vision (HP:0007663) | 1.90121548 |
| 107 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89940439 |
| 108 | Rapidly progressive (HP:0003678) | 1.89174787 |
| 109 | Incomplete penetrance (HP:0003829) | 1.88909425 |
| 110 | Impaired vibratory sensation (HP:0002495) | 1.88822986 |
| 111 | Furrowed tongue (HP:0000221) | 1.88398183 |
| 112 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.87566425 |
| 113 | Hypoplasia of the brainstem (HP:0002365) | 1.87566425 |
| 114 | Vaginal atresia (HP:0000148) | 1.87222742 |
| 115 | Psychosis (HP:0000709) | 1.86611383 |
| 116 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.86467762 |
| 117 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86315647 |
| 118 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.85345779 |
| 119 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.85345779 |
| 120 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.83830275 |
| 121 | Agitation (HP:0000713) | 1.83643464 |
| 122 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.83171395 |
| 123 | Retinal dysplasia (HP:0007973) | 1.82867830 |
| 124 | Widely spaced teeth (HP:0000687) | 1.81908290 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.81306927 |
| 126 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.80539686 |
| 127 | Short 4th metacarpal (HP:0010044) | 1.80539686 |
| 128 | Patellar aplasia (HP:0006443) | 1.80407322 |
| 129 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.80172053 |
| 130 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.79197998 |
| 131 | Short hallux (HP:0010109) | 1.79134299 |
| 132 | Peripheral hypomyelination (HP:0007182) | 1.78764109 |
| 133 | Dyskinesia (HP:0100660) | 1.77513608 |
| 134 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77341163 |
| 135 | Inappropriate behavior (HP:0000719) | 1.77306892 |
| 136 | Status epilepticus (HP:0002133) | 1.76977715 |
| 137 | Poor suck (HP:0002033) | 1.75183187 |
| 138 | Gait imbalance (HP:0002141) | 1.74861665 |
| 139 | Abnormal drinking behavior (HP:0030082) | 1.74681752 |
| 140 | Polydipsia (HP:0001959) | 1.74681752 |
| 141 | Septo-optic dysplasia (HP:0100842) | 1.74573444 |
| 142 | Neuroendocrine neoplasm (HP:0100634) | 1.74477419 |
| 143 | Specific learning disability (HP:0001328) | 1.73802992 |
| 144 | Abnormality of the 4th metacarpal (HP:0010012) | 1.73746977 |
| 145 | Increased corneal curvature (HP:0100692) | 1.73657901 |
| 146 | Keratoconus (HP:0000563) | 1.73657901 |
| 147 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.73553727 |
| 148 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.72902135 |
| 149 | Hypoplasia of the ulna (HP:0003022) | 1.72856105 |
| 150 | Gait ataxia (HP:0002066) | 1.72376783 |
| 151 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.71415164 |
| 152 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.71356335 |
| 153 | Aplasia of the phalanges of the hand (HP:0009802) | 1.71356335 |
| 154 | Aplasia involving bones of the extremities (HP:0009825) | 1.71356335 |
| 155 | Oligodactyly (hands) (HP:0001180) | 1.71329598 |
| 156 | Hemiplegia (HP:0002301) | 1.71168716 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.70344844 |
| 158 | Craniofacial dystonia (HP:0012179) | 1.70006867 |
| 159 | Chorioretinal atrophy (HP:0000533) | 1.69603805 |
| 160 | Concave nail (HP:0001598) | 1.67971533 |
| 161 | Pachygyria (HP:0001302) | 1.66315161 |
| 162 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.64754796 |
| 163 | Postaxial foot polydactyly (HP:0001830) | 1.63648217 |
| 164 | Male pseudohermaphroditism (HP:0000037) | 1.63376139 |
| 165 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.62623634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.97065206 |
| 2 | NTRK3 | 4.89236352 |
| 3 | FRK | 3.68661901 |
| 4 | MARK1 | 3.26538726 |
| 5 | MAP3K9 | 3.23540215 |
| 6 | MAP3K4 | 2.63726737 |
| 7 | MINK1 | 2.56309343 |
| 8 | PINK1 | 2.50440196 |
| 9 | CASK | 2.48556077 |
| 10 | BMPR1B | 2.30662417 |
| 11 | MAP2K7 | 2.23024039 |
| 12 | ADRBK2 | 2.16262108 |
| 13 | NTRK2 | 2.11523431 |
| 14 | RIPK4 | 2.08125592 |
| 15 | MAP3K12 | 2.06589239 |
| 16 | KSR1 | 2.05349881 |
| 17 | TLK1 | 2.05213160 |
| 18 | PNCK | 2.03210281 |
| 19 | TNIK | 2.01168582 |
| 20 | DAPK2 | 1.93190794 |
| 21 | PAK6 | 1.89976209 |
| 22 | KSR2 | 1.88033010 |
| 23 | ZAK | 1.86781227 |
| 24 | GRK1 | 1.82172216 |
| 25 | MAPK13 | 1.73705338 |
| 26 | MAP2K4 | 1.70539375 |
| 27 | ACVR1B | 1.70102373 |
| 28 | PLK2 | 1.67240910 |
| 29 | MAP4K2 | 1.56326148 |
| 30 | NTRK1 | 1.53025970 |
| 31 | DYRK2 | 1.52803481 |
| 32 | PRPF4B | 1.51899874 |
| 33 | CDK5 | 1.48815482 |
| 34 | WNK4 | 1.47823124 |
| 35 | DAPK1 | 1.43388898 |
| 36 | MKNK2 | 1.39982020 |
| 37 | SIK2 | 1.35840529 |
| 38 | ARAF | 1.31224983 |
| 39 | NUAK1 | 1.31018666 |
| 40 | PHKG2 | 1.27701906 |
| 41 | PHKG1 | 1.27701906 |
| 42 | GRK5 | 1.26325384 |
| 43 | PRKD3 | 1.25757761 |
| 44 | INSRR | 1.22295819 |
| 45 | FES | 1.20504107 |
| 46 | PRKCG | 1.19556282 |
| 47 | CDK19 | 1.18858508 |
| 48 | CAMK2A | 1.18730083 |
| 49 | MUSK | 1.17103965 |
| 50 | TRIM28 | 1.16640670 |
| 51 | TYRO3 | 1.15023523 |
| 52 | CSNK1G1 | 1.13055562 |
| 53 | UHMK1 | 1.11915586 |
| 54 | CAMKK1 | 1.11431420 |
| 55 | CAMK2B | 1.10766132 |
| 56 | BMPR2 | 1.04063669 |
| 57 | MAPKAPK5 | 1.02556944 |
| 58 | NME1 | 0.99718460 |
| 59 | MAP3K2 | 0.99607692 |
| 60 | CDK18 | 0.98912302 |
| 61 | OXSR1 | 0.98599271 |
| 62 | MAP3K13 | 0.97518065 |
| 63 | CDK15 | 0.94330571 |
| 64 | CDK14 | 0.92546471 |
| 65 | TAOK3 | 0.92453717 |
| 66 | CSNK1A1L | 0.92274142 |
| 67 | PTK2B | 0.91273053 |
| 68 | CCNB1 | 0.91241196 |
| 69 | BCR | 0.90098832 |
| 70 | TAF1 | 0.88832394 |
| 71 | RAF1 | 0.88386135 |
| 72 | SIK3 | 0.88247088 |
| 73 | CSNK1G2 | 0.87461359 |
| 74 | PAK3 | 0.84741523 |
| 75 | CDK11A | 0.81299665 |
| 76 | FGR | 0.80743242 |
| 77 | LATS2 | 0.79990397 |
| 78 | DYRK1A | 0.79766628 |
| 79 | SGK494 | 0.79369733 |
| 80 | SGK223 | 0.79369733 |
| 81 | STK38 | 0.77631341 |
| 82 | CDC7 | 0.75158472 |
| 83 | SGK1 | 0.74148219 |
| 84 | ADRBK1 | 0.73638823 |
| 85 | CAMK1 | 0.73375496 |
| 86 | STK11 | 0.71510267 |
| 87 | MAPK15 | 0.71496417 |
| 88 | MARK2 | 0.71143468 |
| 89 | MKNK1 | 0.70735852 |
| 90 | FGFR2 | 0.66641931 |
| 91 | AKT3 | 0.63967019 |
| 92 | STK39 | 0.63921577 |
| 93 | VRK1 | 0.63802542 |
| 94 | RET | 0.63777712 |
| 95 | PRKCE | 0.60426040 |
| 96 | CAMK2D | 0.60019593 |
| 97 | SGK2 | 0.58533157 |
| 98 | STK16 | 0.58049937 |
| 99 | CSNK1A1 | 0.55457193 |
| 100 | PRKCH | 0.53036092 |
| 101 | CAMK4 | 0.53007498 |
| 102 | STK38L | 0.50785789 |
| 103 | RPS6KA5 | 0.50675948 |
| 104 | NEK2 | 0.50652036 |
| 105 | PRKCZ | 0.50590798 |
| 106 | NEK6 | 0.50553571 |
| 107 | CSNK1D | 0.48185191 |
| 108 | PKN1 | 0.47619384 |
| 109 | PDPK1 | 0.47345013 |
| 110 | FER | 0.47320692 |
| 111 | ROCK2 | 0.46876875 |
| 112 | CAMK2G | 0.46875316 |
| 113 | TGFBR1 | 0.46287446 |
| 114 | TAOK1 | 0.46119994 |
| 115 | CAMKK2 | 0.44756216 |
| 116 | FYN | 0.44628472 |
| 117 | RPS6KA3 | 0.44296263 |
| 118 | CDK3 | 0.43038527 |
| 119 | PDK1 | 0.42704030 |
| 120 | WNK3 | 0.42469815 |
| 121 | CAMK1G | 0.41571262 |
| 122 | WEE1 | 0.40614331 |
| 123 | DYRK3 | 0.39787681 |
| 124 | MAPK10 | 0.39213329 |
| 125 | LMTK2 | 0.37775685 |
| 126 | MAP3K7 | 0.37645027 |
| 127 | CSNK1G3 | 0.37614655 |
| 128 | MAP2K1 | 0.36809553 |
| 129 | MAP3K6 | 0.36372074 |
| 130 | PLK3 | 0.36299902 |
| 131 | GRK7 | 0.36138810 |
| 132 | SGK3 | 0.34522978 |
| 133 | ERBB2 | 0.33839877 |
| 134 | MAP3K1 | 0.33605223 |
| 135 | PIK3CA | 0.33584974 |
| 136 | PRKACA | 0.33416784 |
| 137 | PRKCA | 0.33154148 |
| 138 | CHEK2 | 0.32915600 |
| 139 | CSNK1E | 0.32088143 |
| 140 | EPHB2 | 0.31587407 |
| 141 | PRKCB | 0.30994729 |
| 142 | PRKG1 | 0.30415239 |
| 143 | BRAF | 0.29840059 |
| 144 | ERBB3 | 0.29611312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.25186057 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94021471 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.85354617 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.80708437 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.76568054 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.75405543 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.73587235 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.59416881 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.56774497 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51065283 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22144149 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.18970245 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03027044 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.90329697 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88260888 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87105667 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84588335 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.83030749 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.81779808 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.78249202 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74557844 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.73209611 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71863299 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65282988 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.61977240 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60533799 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59102238 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56953234 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.56019119 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54295484 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50029330 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47572272 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44344895 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.41648687 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35425858 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.30259434 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28676182 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27997403 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27752332 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26450544 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25746894 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24884454 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21319555 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 1.20358562 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.12918286 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12813860 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.11784667 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 1.11318820 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06508373 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05905688 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03946901 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03480414 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.99388131 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98991814 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97877098 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 0.95800287 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95695445 |
| 58 | RNA polymerase_Homo sapiens_hsa03020 | 0.95106877 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94899328 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 0.93545461 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91117951 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90557363 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90237110 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86620464 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85842492 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85073267 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83258437 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.82997373 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81851064 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78482854 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77396115 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76721203 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76666164 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76389350 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71805957 |
| 76 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71592838 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71381580 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71049638 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69926509 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67397291 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64623155 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62836739 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62758893 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60591712 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60529174 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60286853 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59173641 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57840923 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57551530 |
| 90 | Ribosome_Homo sapiens_hsa03010 | 0.57543785 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57388811 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55512418 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55074710 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54366335 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53244052 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.53130541 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52384193 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52241874 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52175748 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52128902 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52037735 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51783362 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50989435 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49503724 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48288093 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.47603386 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45738038 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45603294 |
| 109 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43756288 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43695639 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.42126683 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41086108 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40502987 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40306710 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40253323 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40128460 |
| 117 | Purine metabolism_Homo sapiens_hsa00230 | 0.39843792 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39838065 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.39334292 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38666618 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38198887 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37875702 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37783111 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36826718 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35776056 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35118906 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33082808 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.32609564 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32375399 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32007569 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.31758948 |
| 132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31199801 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28914130 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28596842 |
| 135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28283851 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27214216 |
| 137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26481027 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25080801 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24391610 |

